Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Draxis Health seeks Canadian approval of modafinil

Aug. 23, 1996

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Calpain inhibitor PD-150606 shows neuroprotective effects

Aug. 16, 1996

SmithKline Beecham takes over Bradycor development

Aug. 16, 1996

Taisho describes NGF production promotors

Aug. 16, 1996

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Sandoz announces Exelon pivotal study results

Aug. 16, 1996

NBI-5788 to enter clinical testing for M.S.

Aug. 16, 1996

Myotrophin expanded access program initiated

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...